Unité de Fabrication des Médicaments Balance Sheet Health
Financial Health criteria checks 5/6
Unité de Fabrication des Médicaments has a total shareholder equity of TND101.8M and total debt of TND31.3M, which brings its debt-to-equity ratio to 30.8%. Its total assets and total liabilities are TND188.3M and TND86.5M respectively. Unité de Fabrication des Médicaments's EBIT is TND30.6M making its interest coverage ratio 4.8. It has cash and short-term investments of TND10.6M.
Key information
30.8%
Debt to equity ratio
د.ت31.32m
Debt
| Interest coverage ratio | 4.8x |
| Cash | د.ت10.62m |
| Equity | د.ت101.84m |
| Total liabilities | د.ت86.46m |
| Total assets | د.ت188.30m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: UMED's short term assets (TND107.6M) exceed its short term liabilities (TND57.8M).
Long Term Liabilities: UMED's short term assets (TND107.6M) exceed its long term liabilities (TND28.7M).
Debt to Equity History and Analysis
Debt Level: UMED's net debt to equity ratio (20.3%) is considered satisfactory.
Reducing Debt: UMED's debt to equity ratio has increased from 22.5% to 30.8% over the past 5 years.
Debt Coverage: UMED's debt is well covered by operating cash flow (83.5%).
Interest Coverage: UMED's interest payments on its debt are well covered by EBIT (4.8x coverage).